15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of a novel pyrazole series of group X secreted phospholipase A2 inhibitor (sPLA2X) via fragment based virtual screening.

Astrazeneca
Inhibition of secreted phospholipases A2 by 2-oxoamides based ona-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.

University of Athens
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.

University of Washington
Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2.

University of Washington
Inhibitory effect of synthetic C-C biflavones on various phospholipase A(2)s activity.

Yeungnam University
Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities.

Université
In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors.

Cnrs Umr 7175
The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding.

University of Washington
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities.

Niddk
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.

Central South University
Quinoline-4-acetamides as sPLA(2) inhibitors.

Peking University
Discovery of AZD2716: A Novel Secreted Phospholipase A

Astrazeneca
Discovery of new non-phospholipid inhibitors of the secretory phospholipases A2.

Fisons
Design of Selective sPLA

Astrazeneca
Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase A

Astrazeneca